Stocks · Health care · Pharmaceutical Preparations

Rapport Therapeutics, Inc.

RAPP Clue Score46
United States Fiscal year ends December CIK 0002012593 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Abraham Ceesay
21 Oct 2026
Chief Executive Officer
Sold on a plan
2,210
$29.16
$64.45K
Abraham Ceesay
7 Oct 2026
Chief Executive Officer
Sold on a plan
1,147
$30.66
$35.17K
Abraham Ceesay
6 Oct 2026
Chief Executive Officer
Sold on a plan
3,375
$32.03
$108.11K

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,428,571
History held since 10 Jun 2024